Results 41 to 50 of about 155,441 (160)

Biopsy-proven hypersensitivity pneumonitis caused by a fluorocarbon waterproofing spray.

open access: yes, 2017
Background We present the case of a 35-year-old male who developed a chronic hypersensitivity pneumonitis (HP) following inhalational exposure to a fluorocarbon waterproofing aerosol spray, caused by his work for an upholstery and soft furnishings ...
Trotter, Simon   +9 more
core   +1 more source

Predictors of Pneumonitis after Lung Cancer Radiotherapy

open access: yes, 2020
Purpose/Objective(s): Multiple factors influence the risk of developing pneumonitis after radiotherapy for lung cancer, but few resources exist to guide clinicians in predicting risk in an individual patient using modern techniques.
McFarlane, M   +19 more
core   +3 more sources

Risk factors for pneumonitis in patients treated with anti‐programmed death‐1 therapy: A case‐control study

open access: yesCancer Medicine, 2018
Immune checkpoint blockade‐related pneumonitis is a rare but potentially life‐threatening adverse effect, but its risk factors are not completely understood.
Pengfei Cui   +14 more
doaj   +1 more source

Delayed onset bleomycin-induced pneumonitis

open access: yes, 2005
We describe a 39-year-old male patient who developed bleomycin-induced pneumonitis 2 years after completion of chemotherapy for nonseminomatous testicular cancer.
Uzel, B   +7 more
core   +1 more source

Early recognition of acute pneumonitis in amiodarone treatment

open access: yesHeart Views, 2018
Pulmonary complications of long-term amiodarone use are well known. However, acute pneumonitis causing respiratory distress with short-term administration of amiodarone although rare is associated with high mortality.
Rishi Vinod Lohiya, Manoj P Pethe
doaj   +1 more source

Thoracotomy for Empyema Thoracis—Relevant as Ever in Children, as Timely Referral is Still a Concern: An Observational Study [PDF]

open access: yesPediatric Infectious Disease
Aims and background: There are several options for treating empyema thoracis (ET), ranging from conservative therapies to surgical intervention, depending on the stage of the condition. The optimal management strategy for later stages, particularly stage
Neel Aggerwal   +3 more
doaj   +1 more source

Successful osimertinib retreatment after extremely early onset severe pneumonitis in first‐line treatment of lung adenocarcinoma

open access: yesThoracic Cancer, 2020
Drug‐induced pneumonitis is rare, and can result in death. Here, we present a report of a patient with adenocarcinoma harboring EGFR exon 19 deletion mutation treated with osimertinib as first‐line treatment.
June Hong Ahn
doaj   +1 more source

Treatment rechallenge is safe and leads to better survival in pancreatic cancer patients with interstitial pneumonitis

open access: yesBMC Cancer
Background and aims Interstitial pneumonitis is a potentially fatal complication of cancer-related therapy. However, data regarding the risk factors, prognosis and safety and benefit of rechallenge treatment are scarce.
Hung-Yuan Yu   +5 more
doaj   +1 more source

Radiation-Induced Lung Injury (RILI)

open access: yesFrontiers in Oncology, 2019
Radiation pneumonitis (RP) and radiation fibrosis (RF) are two dose-limiting toxicities of radiotherapy (RT), especially for lung, and esophageal cancer.
Lorena Giuranno   +3 more
doaj   +1 more source

Fulminant lupus pneumonitis complicating systemic lupus erythematosus in the elderly

open access: yesClinical Case Reports, 2023
Fulminant lupus pneumonitis is a rare complication of SLE. We report a case of 75 years‐old male patient with SLE who developed pneumonia and severe respiratory failure requiring mechanical ventilation.
Wiem Helali   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy